MicroRNA-23a-3p inhibitor decreases osteonecrosis incidence in a rat model

Mol Med Rep. 2017 Dec;16(6):9331-9336. doi: 10.3892/mmr.2017.7808. Epub 2017 Oct 17.

Abstract

The mechanism of steroid-associated femoral head necrosis remains unclear. The present study investigated the role of microRNA-23a-3p (miR-23a-3p) in the incidence of osteonecrosis in a rat model. An miR-23a-3p mimic, an inhibitor and a negative control were transfected into bone mesenchymal stem cells using a lentiviral vector, and then injected into the steroid-induced femoral head necrosis model. Osteonecrosis incidence was assessed by micro computed tomography and histopathology. Low-density lipoprotein receptor-related protein 5 (LRP-5) expression was assessed by immunohistochemistry. The results demonstrated the incidence of osteonecrosis decreased in the miR-23a-3p inhibitor group compared with the miR-23a-3p mimic group (18.2% vs. 75%; P<0.05). The ratio of bone volume/total volume and trabecular thickness were significantly increased in the miR-23a-3p inhibitor group compared with the miR-23a mimic group. The expression level of LRP-5 was higher in the miR-23a-3p inhibitor group. The present study indicated that miR may provide a novel and alternative approach for understanding the mechanism underlying steroid-associated necrosis of the femoral head.

MeSH terms

  • Animals
  • Bone Density
  • Cancellous Bone / diagnostic imaging
  • Cancellous Bone / pathology
  • Disease Models, Animal
  • Femur Head / diagnostic imaging
  • Femur Head / pathology
  • Incidence
  • Male
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • MicroRNAs / antagonists & inhibitors
  • MicroRNAs / metabolism*
  • Osteonecrosis / pathology*
  • Osteonecrosis / therapy*
  • Rats, Sprague-Dawley
  • X-Ray Microtomography

Substances

  • MIRN23 microRNA, rat
  • MicroRNAs